IL141539A0 - Dna molecules and cells transfected therewith - Google Patents
Dna molecules and cells transfected therewithInfo
- Publication number
- IL141539A0 IL141539A0 IL14153901A IL14153901A IL141539A0 IL 141539 A0 IL141539 A0 IL 141539A0 IL 14153901 A IL14153901 A IL 14153901A IL 14153901 A IL14153901 A IL 14153901A IL 141539 A0 IL141539 A0 IL 141539A0
- Authority
- IL
- Israel
- Prior art keywords
- dna molecules
- cells transfected
- transfected therewith
- therewith
- cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL14153901A IL141539A0 (en) | 2001-02-20 | 2001-02-20 | Dna molecules and cells transfected therewith |
IL15748502A IL157485A0 (en) | 2001-02-20 | 2002-02-20 | T cell receptor variants expressed in mesenchymal cells and uses thereof |
IL15748402A IL157484A0 (en) | 2001-02-20 | 2002-02-20 | Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
EP02712231A EP1389236B1 (en) | 2001-02-20 | 2002-02-20 | Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
AU2002232107A AU2002232107B2 (en) | 2001-02-20 | 2002-02-20 | Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
CA002438775A CA2438775A1 (en) | 2001-02-20 | 2002-02-20 | T cell receptor variants expressed in mesenchymal cells and uses thereof |
JP2002566353A JP2004529625A (ja) | 2001-02-20 | 2002-02-20 | 間葉細胞中で発現される免疫グロブリンスーパーファミリー変種とその使用 |
PCT/IL2002/000130 WO2002066636A2 (en) | 2001-02-20 | 2002-02-20 | T cell receptor variants expressed in mesenchymal cells and uses thereof |
EP02712232A EP1362104A2 (en) | 2001-02-20 | 2002-02-20 | T cell receptor variants expressed in mesenchymal cells and uses thereof |
AT02712231T ATE342982T1 (de) | 2001-02-20 | 2002-02-20 | Varianten der immunglobulin superfamilie exprimiert in mesenchymalen zellen und deren therapeutische verwendungen |
CA002438769A CA2438769A1 (en) | 2001-02-20 | 2002-02-20 | Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
PCT/IL2002/000129 WO2002066648A2 (en) | 2001-02-20 | 2002-02-20 | Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
DE60215487T DE60215487D1 (de) | 2001-02-20 | 2002-02-20 | Varianten der immunglobulin superfamilie exprimiert in mesenchymalen zellen und deren therapeutische verwendungen |
JP2002566342A JP2004529624A (ja) | 2001-02-20 | 2002-02-20 | 間葉細胞中で発現されるt細胞受容体変種とその使用 |
US10/642,642 US20040259196A1 (en) | 2001-02-20 | 2003-08-19 | T cell receptor variants expressed in mesenchymal cells and uses thereof |
US10/643,982 US20040101931A1 (en) | 2001-02-20 | 2003-08-20 | Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
US11/657,211 US20070196365A1 (en) | 2001-02-20 | 2007-01-23 | Immunoglobulin heavy chain variants expressed in mesenchymal cells and therapeutic uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL14153901A IL141539A0 (en) | 2001-02-20 | 2001-02-20 | Dna molecules and cells transfected therewith |
Publications (1)
Publication Number | Publication Date |
---|---|
IL141539A0 true IL141539A0 (en) | 2002-03-10 |
Family
ID=11075149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14153901A IL141539A0 (en) | 2001-02-20 | 2001-02-20 | Dna molecules and cells transfected therewith |
Country Status (6)
Country | Link |
---|---|
US (1) | US20040259196A1 (ja) |
EP (1) | EP1362104A2 (ja) |
JP (1) | JP2004529624A (ja) |
CA (1) | CA2438775A1 (ja) |
IL (1) | IL141539A0 (ja) |
WO (1) | WO2002066636A2 (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7994298B2 (en) | 2004-09-24 | 2011-08-09 | Trustees Of Dartmouth College | Chimeric NK receptor and methods for treating cancer |
EP2028193B1 (en) | 2005-01-05 | 2012-03-07 | f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. | Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
AT503861B1 (de) | 2006-07-05 | 2008-06-15 | F Star Biotech Forsch & Entw | Verfahren zur manipulation von t-zell-rezeptoren |
AT503889B1 (de) | 2006-07-05 | 2011-12-15 | Star Biotechnologische Forschungs Und Entwicklungsges M B H F | Multivalente immunglobuline |
WO2009000006A1 (en) | 2007-06-26 | 2008-12-31 | F-Star Biotechnologische Forschungs- Und Entwicklungsges.M.B.H. | Display of binding agents |
EP2113255A1 (en) | 2008-05-02 | 2009-11-04 | f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. | Cytotoxic immunoglobulin |
WO2011059836A2 (en) | 2009-10-29 | 2011-05-19 | Trustees Of Dartmouth College | T cell receptor-deficient t cell compositions |
US9273283B2 (en) | 2009-10-29 | 2016-03-01 | The Trustees Of Dartmouth College | Method of producing T cell receptor-deficient T cells expressing a chimeric receptor |
WO2013033626A2 (en) | 2011-08-31 | 2013-03-07 | Trustees Of Dartmouth College | Nkp30 receptor targeted therapeutics |
JP6389166B2 (ja) | 2012-05-07 | 2018-09-12 | トラスティーズ・オブ・ダートマス・カレッジ | 抗b7−h6抗体、融合タンパク質、及びこれらを使用する方法 |
US20220275043A1 (en) | 2018-07-17 | 2022-09-01 | Massachusetts Institute Of Technology | Soluble multimeric immunoglobulin-scaffold based fusion proteins and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020137081A1 (en) * | 2001-01-08 | 2002-09-26 | Olga Bandman | Genes differentially expressed in vascular tissue activation |
-
2001
- 2001-02-20 IL IL14153901A patent/IL141539A0/xx unknown
-
2002
- 2002-02-20 WO PCT/IL2002/000130 patent/WO2002066636A2/en active Search and Examination
- 2002-02-20 JP JP2002566342A patent/JP2004529624A/ja active Pending
- 2002-02-20 CA CA002438775A patent/CA2438775A1/en not_active Abandoned
- 2002-02-20 EP EP02712232A patent/EP1362104A2/en not_active Withdrawn
-
2003
- 2003-08-19 US US10/642,642 patent/US20040259196A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2438775A1 (en) | 2002-08-29 |
WO2002066636A2 (en) | 2002-08-29 |
EP1362104A2 (en) | 2003-11-19 |
US20040259196A1 (en) | 2004-12-23 |
WO2002066636A3 (en) | 2002-11-28 |
JP2004529624A (ja) | 2004-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1253942A4 (en) | CD40-BINDING AND APC-ACTIVATING MOLECULES | |
IL197159A0 (en) | Rna molecules and pharmaceutical compositions containing the same | |
EP1284752A4 (en) | BISPECIFIC MOLECULES AND USES THEREOF | |
AU4196801A (en) | Chordin-like-2 molecules and uses thereof | |
EP1392106A4 (en) | TYRA GENES AND ITS USE | |
IL141539A0 (en) | Dna molecules and cells transfected therewith | |
EP1147213A4 (en) | RGS-CONTAINING MOLECULES AND THEIR USE | |
EP1119253A4 (en) | NEW SPECIFIC MOLECULES OF Th2 AND USES THEREOF | |
IL128193A0 (en) | Rhamnosyl-transferase gene and uses thereof | |
EP1186615A4 (en) | PROTEIN AND DNA OF THIS PROTEIN | |
EP1425289A4 (en) | NOVEL NUCLEIC ACID AND POLYPEPTIDE MOLECULES | |
AU2001264852A1 (en) | Lactobacillusbeta -glucuronidase and dna encoding the same | |
IL138216A0 (en) | Novel fdrg protein and nucleic acid molecules and uses therefor | |
EP1293568A4 (en) | PROTEIN AND ITS DNA | |
AU2001270478A1 (en) | Gene expression in biological conditions | |
EP1071749A4 (en) | NUCLEIC ACID AND LRSG PROTEIN MOLECULES AND USES THEREOF | |
GB0102717D0 (en) | Cells and uses therefor | |
EP1177207A4 (en) | DNA ENCODING THE PROSTATE-SPECIFIC MEMBRANE-ANTIGAN GENE AND THEIR USE | |
GB0115780D0 (en) | Therapeutic molecules and uses thereof | |
AU2001249929A1 (en) | Fdrg proteins and nucleic acid molecules and uses therefor | |
IL145658A0 (en) | Dna molecules and cells transfected therewith | |
IL134064A0 (en) | Dna molecules and cells transfected therewith | |
GB0022670D0 (en) | Molecules | |
GB2361698B (en) | Modification of DNA molecules | |
EP1293510A4 (en) | POLYPEPTIDE AND ITS DNA |